Big Pharma Wants You to Magically Lose Weight with Ozempic:  Its Newest Cash Cow

Latest

Big Pharma magic bullet, Ozempic.
Big Pharma magic bullet. Novo Nordisk, producer of Ozempic, made a gross profit of $22.244B for the 12 months ending March 31, 2023, a 14.69% increase over last year.

Ozempic (semaglutide) is a weekly injectable medicine for adults to improve blood sugar and reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with Type 2 diabetes and known heart disease, and results in weight loss. It is made by Novo Nordisk, a Danish pharmaceutical company. It belongs to the class of medicines called GLP-1 receptor agonists.

Common side effects are nausea, diarrhea, constipation, stomach pain, vomiting, sulfur burps, and hair loss. Serious side effects can be thyroid tumors, including cancer, pancreatitis, changes in vision, hypoglycemia, serious allergic reactions, gallbladder problems, and jaundice.

It is unknown if Ozempic will harm an unborn baby or passes into breast milk. Ozempic must be stopped two months before pregnancy. Ozempic is not for use in people with Type 1 diabetes. It is unknown if Ozempic is safe and effective for use in children under 18 years of age.

Online pharmacies, medical spas and diet clinics run thousands of weight-loss ads on social media for Ozempic. When a drug takes over the internet, it takes over the world. There are more than 4,000 ads for Ozempic-style drugs running on Instagram and Face-book. The ads are everywhere: on television, at signs near public transit, on the walls of air-ports, and most surfaces devoted to marketing.

According to the FDA, there are no approved generic versions of semaglutide. Accordingly, there are counterfeit drugs. See https://www. youtube.com/watch?v=Sve2k8TYrOY&t=296s. The cost for Ozempic subcutaneous solution (2 mg/1.5 mL (0.25 mg or 0.5 mg dose)) is around $995 for a supply of 1.5 milliliters. There are coupons: some for $25 a month for 24 months by the Novo Nordisk. Kroger has one for $250 off, and there are fake coupons.

Ozempic is intended for long-term use. After some significant weight loss occurs in about two years, financial assistance will be exhausted, regular insurance won’t cover it due to its cost, and then what? Most will have to stop taking it, weight will rebound. Folks risked serious health problems only to return to where they started.

If there was a magic bullet for weight loss, it would be diet and exercise-related. Let’s get back to work. Losing weight takes time and lifestyle changes. It’s not impossible, just slow. As always, see your doctor for the best advice.

+ Articles by this author

Kathy Powers is a lifetime Chicagoan. At 50, Kathy speaks out as the voice of the people. She became a revolutionary activist whose lifelong fight raises unheard voices. She is the Health Care Desk on the People’s Tribune Editorial Board.

Free to republish but please credit the People's Tribune. Visit us at www.peoplestribune.org, email peoplestribune@gmail.com, or call 773-486-3551.

The People’s Tribune brings you articles written by individuals or organizations, along with our own reporting. Bylined articles reflect the views of the authors. Unsigned articles reflect the views of the editorial board. Please credit the source when sharing: ©2024 peoplestribune.org. Please donate to help us keep bringing you voices of the movement. Click here. We’re all volunteer, no paid staff.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Featured

Chicagoans Vow to Fight Trump’s Attack on Immigrant Workers

Chicagoans are showing that they plan to resist President Trump’s plans to mount attacks on immigrants.

A Mass Movement Will Rise to Defend Immigrants, Says Activist

Right now there is no coordinated national mass movement to defend immigrants, but there will be, says human rights activist Camilo Pérez-Bustillo in this interview with the People's Tribune.

L.A. Fires: Climate Campaigners Say ‘Big Oil Did This’

Climate campaigners said blame for the catastrophe in L.A. ultimately lies with the mega-profitable oil and gas giants that have spent decades  knowingly fueling the crisis.

Collective Defense of Immigrant Rights is Key, Says Advocate

In this interview with the People's Tribune, Pedro Rios, director of the AFSC's US/Mexico Border Program, describes the likely shape of Trump's planned immigration crackdown, and how people are organizing to resist it.

US Workers Won Key Victories in 2024, But Hard Fight Lies Ahead

With strikes and the threat of strikes, workers did more than forestall concessions: They gained ground. With Trump, expect attacks on unions, safety regulations, and the very idea of labor law..

More from the People's Tribune